Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27659481 | 0.98 | ALDH1A1 (0.55) | ALDH1A1MAPTALOX15L3MBTL1KDM4E | |
| SCHEMBL2201868 | 0.98 | ALDH1A1 (0.51) | ALDH1A1MAPTALOX15L3MBTL1KDM4E | |
| SCHEMBL30408019 | 0.93 | ALDH1A1 (0.51) | ALDH1A1MAPTALOX15L3MBTL1KDM4E | |
| SCHEMBL9658891 | 0.87 | SLC2A1 (0.49) | ALDH1A1MAPTALOX15L3MBTL1KDM4E | |
| SCHEMBL14982059 | 0.86 | RAB9A (0.54) | ALDH1A1MAPTALOX15L3MBTL1KDM4E | |
| SCHEMBL10473357 | 0.86 | MEN1 (0.54) | ALDH1A1MAPTALOX15L3MBTL1KDM4E | |
| SCHEMBL10472949 | 0.86 | MEN1 (0.54) | ALDH1A1MAPTALOX15L3MBTL1KDM4E | |
| SCHEMBL11638317 | 0.85 | SLC2A1 (0.46) | ALDH1A1MAPTALOX15L3MBTL1KDM4E | |
| SCHEMBL5950454 | 0.85 | MAPT (0.53) | ALDH1A1MAPTALOX15L3MBTL1KDM4E | |
| SCHEMBL10473803 | 0.84 | MEN1 (0.56) | ALDH1A1MAPTALOX15L3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103756257-A | Thermosetting epoxy resin composition and use thereof | SHENGYI TECHNOLOGY CO LTD | 2014-04-30 | — | — | CN | claimed |
| CN-1566117-A | Fluorine quinolone compounds and synthetic method thereof | BEIJING DOUBLE CRANE PHARMACEU (CN) | 2005-01-19 | — | — | CN | claimed |
| CN-109833484-A | A kind of Pegylation polylysine-hydroxycamptothecin nano grain preparation method without methotrexate and containing methotrexate (MTX) | 湖南师范大学 | 2019-06-04 | — | — | CN | disclosed |
| CN-104254521-B | Trans-2-decylenic acid derivative and the medicine that contains it | NIPPON ZOKI PHARMACEUTICAL CO.,LTD. (JP) | 2016-05-04 | — | — | CN | disclosed |
| CN-104177313-A | 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS | AXIKIN PHARMACEUTICALS INC | 2014-12-03 | — | — | CN | disclosed |
| CN-102186856-B | Pyrrolopyrimidines as CDK inhibitors | NOVARTIS AG | 2014-09-24 | — | — | CN | disclosed |
| CN-104059066-A | Diazacarbazoles And Methods Of Use | GENENTECH INC | 2014-09-24 | — | — | CN | disclosed |
| CN-103788100-A | Pyrrolopyrimidine compounds as CDK inhibitors | NOVARTIS AG | 2014-05-14 | — | — | CN | disclosed |
| CN-103756257-A | Thermosetting epoxy resin composition and use thereof | SHENGYI TECHNOLOGY CO LTD | 2014-04-30 | — | — | CN | disclosed |
| CN-102414191-B | 4 -isopropylphenyl glucitol compounds as sgltl inhibitors | TAISHO PHARMACEUTICAL CO LTD | 2014-04-16 | — | — | CN | disclosed |
| CN-101835779-B | Purine derivatives useful as PI3 kinase inhibitors | HOFFMANN LA ROCHE | 2014-01-29 | — | — | CN | disclosed |
| CN-1297442-A | 5-aminoindeno [1,2-c] pyrazol-4-ones as anti-cancer and anti-proliferative agents | DU PONT PHARM CO (US) | 2001-05-30 | — | — | CN | disclosed |
| CN-1064042-C | Intermediate of benzazepine derivative | YAMANOUCHI PHARMA CO LTD (JP) | 2001-04-04 | — | — | CN | disclosed |
| CN-1270960-A | Process for preparing growth hormone secretagogue | PFIZER PROD INC (US) | 2000-10-25 | — | — | CN | disclosed |
| CN-1234790-A | Oligosaccharide synthesis | ALCHEMIA CO LTD (AU) | 1999-11-10 | — | — | CN | disclosed |
| CN-1218047-A | Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them | HOECHST MARION ROUSSEL DE GMBH (DE) | 1999-06-02 | — | — | CN | disclosed |
| CN-1040748-C | Benzazepine derivatives, pharmaceutical compositions and intermediates thereof | YAMANOUCHI PHARMA CO LTD (JP) | 1998-11-18 | — | — | CN | disclosed |
| CN-1198437-A | Intermediate of benzazepine derivative | YAMANOUCHI PHARMA CO LTD (JP) | 1998-11-11 | — | — | CN | disclosed |
| CN-1129934-A | Benzazepine derivatives, pharmaceutical compositions and intermediates thereof | YAMANOUCHI PHARMA CO LTD (JP) | 1996-08-28 | — | — | CN | disclosed |
| CN-87105777-A | Heterogeneous ring compound | — | 1988-04-06 | — | — | CN | disclosed |